Perspective Therapeutics to Participate at Upcoming Investor Conferences in August
Perspective Therapeutics (NYSE AMERICAN: CATX), a pioneering radiopharmaceutical company, has announced its participation in two upcoming investor conferences in August 2024.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Perspective Therapeutics (NYSE AMERICAN: CATX), a pioneering radiopharmaceutical company, has announced its participation in two upcoming investor conferences in August 2024. The company's senior leadership team will be available for one-on-one meetings with investors at both events.
The first conference is the BTIG Virtual Biotechnology Conference, scheduled for August 5-6, 2024, which will be held virtually. The second is the 2024 Wedbush PacGrow Healthcare Conference, taking place in-person in New York, NY on August 13-14, 2024.
At the Wedbush conference, Perspective Therapeutics will also participate in a panel discussion titled 'Nuke 'em From Orbit: Radiotherapy' at 9:30am ET. This engagement highlights the company's focus on advanced treatment applications for cancers throughout the body using radiopharmaceuticals.
Details
News Market Reaction – CATX
The recorded move for CATX in the trading session of this news was -0.55%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SEATTLE, July 30, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today announced that members of its senior leadership team will be available for one-on-one meetings with investors in the following upcoming investor conferences as well as a panel discussion as noted.
BTIG Virtual Biotechnology Conference 2024
Date: August 5-6, 2024
Location: Virtual
2024 Wedbush PacGrow Healthcare Conference
Date: August 13-14, 2024
Location: New York, NY (in-person only)
Panel Discussion - Nuke ‘em From Orbit: Radiotherapy
Time: 9:30am ET
About Perspective Therapeutics, Inc.
Perspective Therapeutics, Inc., is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides. The Company is also developing complementary imaging diagnostics that incorporate the same targeting peptides which provide the opportunity to personalize treatment and optimize patient outcomes. This "theranostic" approach enables the ability to see the specific tumor and then treat it to potentially improve efficacy and minimize toxicity.
The Company's melanoma (VMT01) and neuroendocrine tumor (VMT-α-NET) programs have entered Phase 1/2a imaging and therapy trials for the treatment of metastatic melanoma and neuroendocrine tumors at several leading academic institutions. The Company has also developed a proprietary 212Pb generator to secure key isotopes for clinical trial and commercial operations.
For more information, please visit the Company's website at www.perspectivetherapeutics.com.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.